Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 5
2001 3
2002 2
2003 2
2004 5
2005 2
2006 3
2008 3
2009 5
2010 6
2011 2
2012 2
2013 4
2014 2
2015 2
2016 5
2017 5
2018 3
2019 4
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, O'Callaghan FJ, Wong M, Sahebkar F, Checketts D, Knappertz V; GWPCARE6 Study Group. Thiele EA, et al. Among authors: o callaghan fj. JAMA Neurol. 2021 Mar 1;78(3):285-292. doi: 10.1001/jamaneurol.2020.4607. JAMA Neurol. 2021. PMID: 33346789 Free PMC article. Clinical Trial.
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP; United Kingdom Infantile Spasms Study. Lux AL, et al. Among authors: o callaghan fj. Lancet Neurol. 2005 Nov;4(11):712-7. doi: 10.1016/S1474-4422(05)70199-X. Lancet Neurol. 2005. PMID: 16239177 Clinical Trial.
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, Likeman M, Lux AL, Mackay M, Mallick AA, Newton RW, Nolan M, Pressler R, Rating D, Schmitt B, Verity CM, Osborne JP; participating investigators. O'Callaghan FJ, et al. Lancet Neurol. 2017 Jan;16(1):33-42. doi: 10.1016/S1474-4422(16)30294-0. Epub 2016 Nov 10. Lancet Neurol. 2017. PMID: 27838190 Free article. Clinical Trial.
Tuberous sclerosis.
O'Callaghan FJ. O'Callaghan FJ. BMJ. 1999 Apr 17;318(7190):1019-20. doi: 10.1136/bmj.318.7190.1019. BMJ. 1999. PMID: 10205080 Free PMC article. No abstract available.
Epilepsy in childhood and quality of life.
O'Callaghan FJ. O'Callaghan FJ. Eur J Paediatr Neurol. 2015 May;19(3):276-7. doi: 10.1016/j.ejpn.2015.03.004. Epub 2015 Mar 13. Eur J Paediatr Neurol. 2015. PMID: 25800878 No abstract available.
The epidemiology of childhood stroke.
Mallick AA, O'Callaghan FJ. Mallick AA, et al. Among authors: o callaghan fj. Eur J Paediatr Neurol. 2010 May;14(3):197-205. doi: 10.1016/j.ejpn.2009.09.006. Epub 2009 Oct 30. Eur J Paediatr Neurol. 2010. PMID: 19879783 Review.
Epilepsy related mortality.
O'Callaghan FJ, Osborne JP, Martyn CN. O'Callaghan FJ, et al. Arch Dis Child. 2004 Aug;89(8):705-7. doi: 10.1136/adc.2003.036558. Arch Dis Child. 2004. PMID: 15269065 Free PMC article. No abstract available.
Shaken impact syndrome.
Lux AL, Walker SG, O'Callaghan FJ, Greeley CS. Lux AL, et al. Among authors: o callaghan fj. Lancet. 2001 Apr 14;357(9263):1207. doi: 10.1016/S0140-6736(00)04355-5. Lancet. 2001. PMID: 11332435 No abstract available.
Tuberous sclerosis complex and Wolff-Parkinson-White syndrome.
O'Callaghan FJ, Clarke AC, Joffe H, Keeton B, Martin R, Salmon A, Thomas RD, Osborne JP. O'Callaghan FJ, et al. Arch Dis Child. 1998 Feb;78(2):159-62. doi: 10.1136/adc.78.2.159. Arch Dis Child. 1998. PMID: 9579160 Free PMC article. Review.
60 results